BDNF recombinant proteins refer to engineered versions of Brain-Derived Neurotrophic Factor (BDNF), a key neurotrophic factor involved in brain development, neuronal survival, and synaptic plasticity. BDNF is crucial for the maintenance and function of neurons and plays a significant role in cognitive functions and neuroplasticity. Recombinant BDNF proteins are used in various research applications, therapeutic developments, and diagnostic tests related to neurological health and disease.

Structure and Function
  • Brain-Derived Neurotrophic Factor (BDNF) is a protein composed of approximately 119 amino acids in its mature form. It is synthesized as a precursor protein (proBDNF) that is cleaved to produce the mature BDNF.
  • BDNF is involved in promoting neuronal survival, differentiation, and synaptic plasticity. It acts by binding to its receptors, primarily the TrkB (tropomyosin receptor kinase B) receptor, and modulating various intracellular signaling pathways that support neuronal health and growth.
  • Recombinant BDNF proteins typically include the full-length mature BDNF peptide or specific variants for targeted research and therapeutic purposes.

Production
  • Recombinant BDNF proteins are produced using expression systems such as E. coli, yeast, insect cells, or mammalian cells, depending on the need for correct folding and post-translational modifications.
  • The gene encoding BDNF is cloned into an expression vector, followed by protein expression and purification using affinity chromatography techniques. Tags such as His-tag or GST-tag are commonly used to facilitate the purification process.

Applications
  • Neuroscience Research: Recombinant BDNF proteins are used to investigate neuronal growth, survival, and synaptic plasticity. They help researchers understand the role of BDNF in brain function, learning, memory, and neurodegenerative diseases.
  • Neurodegenerative Diseases: BDNF is explored as a potential therapeutic agent for conditions such as Alzheimer’s disease, Parkinson’s disease, and depression. Recombinant BDNF proteins are used in preclinical studies to evaluate their efficacy in promoting neuronal health and cognitive function.
  • Mental Health Research: BDNF has been implicated in mood disorders and cognitive impairments. Recombinant BDNF proteins are used to study their effects on mental health and to explore potential treatments for mood disorders and cognitive deficits.
  • Regenerative Medicine: BDNF is studied for its potential in enhancing nerve regeneration and recovery after injury. Recombinant BDNF proteins are employed in experimental models to assess their ability to support nerve repair and functional recovery.

Validation and Quality Control
  • Validation of recombinant BDNF proteins involves confirming their identity, purity, and biological activity through methods such as SDS-PAGE, Western blotting, and mass spectrometry.
  • Functional assays, including receptor-binding studies and cell-based assays, are performed to ensure that the recombinant proteins exhibit the expected neurotrophic activity and interact correctly with their receptors.
AffiREC® Recombinant Human BDNF Protein, No Tag
CAT# AFG-KMD-20183
Size: 100 μg
1,488.50 1488.5 USD
AffiREC® BDNF
CAT# AFG-NRM-0175
Size: 100 ug
642.75 642.75 USD
AffiREC® Recombinant feline BDNF protein
CAT# AFG-GNS-4418
Size: 5 mg
607.50 607.5 USD
AffiREC® Recombinant Hamster BDNF Protein
CAT# AFG-GNS-6486
Size: 5 µg
607.50 607.5 USD
AffiREC® Recombinant Equine BDNF protein
CAT# AFG-GNS-0528
Size: 5 µg
607.50 607.5 USD
398.50 398.5 USD
398.50 398.5 USD
398.50 398.5 USD
AffiREC® Recombinant Human/Murine/Rat BDNF
CAT# AFG-EPR-0271
Size: 50 µg
696.15 696.15 USD
AffiREC® Recombinant Human pro-BDNF
CAT# AFG-EPR-0095
Size: 10 µg
169.15 169.15 USD